About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 14 results:

Short communication

A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large protease/reverse transcriptase and co-receptor tropism database from 2003 to 2012

Agnes C Paquet, Owen D Solberg, Laura A Napolitano, Joseph M Volpe, Charles Walworth, Jeannette M Whitcomb, Christos J Petropoulos, Mojgan Haddad

Antiviral Therapy 2014; 19:435-441


Short communication

CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1–HBV coinfection following HBV-active antiretroviral therapy

Paola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, Jennifer Audsley, Pip Marks, Gail Matthews, Kiat Ruxrungtham, Sharon R Lewin, Megan Crane

Antiviral Therapy 2014; 19:429-433


Short communication

Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B

Pauline Arends, Annemiek A van der Eijk, Milan J Sonneveld, Bettina E Hansen, Harry LA Janssen, Bart L Haagmans

Antiviral Therapy 2014; 19:423-427


Original article

Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C

Christopher B Hurt, Sonia Napravnik, Richard D Moore, Joseph J Eron

Antiviral Therapy 2014; 19:415-422


Original article

Strategies for assignment of HIV–HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

Mattias Mandorfer, Karin Neukam, Antonio Rivero, Massimo Puoti, Christoph Boesecke, Axel Baumgarten, Anna Grzeszczuk, Robert Zangerle, Diana Ernst, Jürgen Kurt Rockstroh, Michael Trauner, Juan Antonio Pineda, Markus Peck-Radosavljevic, Thomas Reiberger

Antiviral Therapy 2014; 19:407-414


Original article

Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen

Retsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, Sandra Meredith, Lubbe Wiesner, Ashraf Coovadia, Renate Strehlau, Leigh Martens, Elaine J Abrams, Gary Maartens, Helen McIlleron

Antiviral Therapy 2014; 19:399-406


Original article

Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000–2010

Sayonara R Ribeiro, Paula M Luz, Dayse P Campos, Ronaldo I Moreira, Lara Coelho, André Japiassu, Fernando Bozza, Valdilea G Veloso, Genevieve Chene, Beatriz Grinsztejn

Antiviral Therapy 2014; 19:387-397


Original article

Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort

María Jesús Pérez-Elías, Alfonso Muriel, Ana Moreno, María Martinez-Colubi, José A Iribarren, Mar Masiá, José R Blanco, Rosario Palacios, Jorge del Romero, Desire G Pérez, Victoria Hernando, CoRIS Study Group

Antiviral Therapy 2014; 19:375-385


Original article

Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes

Carol Crowther, Mohube B Mowa, Abdullah Ely, Patrick B Arbuthnot

Antiviral Therapy 2014; 19:363-373


Free
Original article

Intravenous peramivir for treatment of influenza in hospitalized patients

Michael G Ison, Joseph Fraiz, Barry Heller, Luis Jauregui, Graham Mills, William O’Riordan, Brian O’Neil, E Geoffrey Playford, J Douglass Rolf, Eduardo Sada-Diaz, Jenna Elder, Phil Collis, Jaime E Hernandez, William P Sheridan

Antiviral Therapy 2014; 19:349-361


Page:
Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.